Members of Camargo plan to attend, present and/or exhibit at the following meetings and events.


Click here to schedule a meeting during a show. 


The 505(b)(2) Forum

The 505(b)(2) Pathway: A Case-by-Case Review of New Technologies and Development Techniques

Event held at the GPhA Fall Technical Conference

Oct. 27, 2014

6:30 – 9 p.m.

Marriott Hotel and Conference Center

North Bethesda, MD


Click here for more information about the event co-hosted by Camargo Pharmaceutical Service and to learn about seating availability.


GPhA Fall Technical Conference

Oct. 27-29, 2014

North Bethesda, MD


Click here for more information


AAPS Annual Meeting

Booth #3505

Nov. 2-6, 2014

San Diego, CA


Click here for more information


AAPS 505(b)(2) Luncheons

Monday: Bridging to the Listed Drug
Bridging studies close the gap between your product and known safety and efficacy for reference listed drugs — first, identify when bridging studies are necessary and second, learn how to optimize them for faster, more cost-effective development.

Tuesday: How to Earn Exclusivity
Your product may have more commercial potential than you know: 505(b)(2) development applicants may qualify for up to three, five or even seven years of market exclusivity.

AAPS Open Forum

Streamlining Manufacturing and Scale-Up to Support “Breakthrough Therapy” Designation for Solid Oral Dosage Forms
Cosponsored by Camargo Pharmaceutical Services, Takeda Pharmaceuticals International and Pfizer.

Learn about the FDA’s “breakthrough therapy” designation and a new manufacturing model being developed for scaling-up these niche indication, low-volume drug products.